Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.285 USD | -2.52% | +0.15% | +9.70% |
Apr. 04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
Apr. 01 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.70% | 176M | |
-3.04% | 102B | |
+1.76% | 96.29B | |
+2.18% | 22.18B | |
-15.28% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.74% | 16.36B | |
+5.56% | 13.97B | |
+31.91% | 12.17B |
- Stock Market
- Equities
- KOD Stock
- News Kodiak Sciences Inc.
- UBS Lowers Kodiak Sciences Price Target to $15 From $121 as Path Forward After DAZZLE Trial Miss is 'Challenging', Reiterates Buy Rating